David Finegold Strategy & Organization Studies, Keck Graduate Institute for the Applied Life SciencesCecile Bensimon University of Toronto Joint Centre for BioethicsAbdallah Daar University of Toronto Joint Centre for BioethicsMargaret Eaton Stanford University Center for Biomedical EthicsBeatrice Godard Facult?de m?ecine, Universit?de Montr?lBartha Knoppers Facult?de droit, Universit?de Montr?lJocelyn Mackie University of Toronto Joint Centre for BioethicsPeter Singer University of Toronto Joint Centre for Bioethics
Measurements: 6 X 9 in
Imprint: Academic Press
Publication Date: 10 June 2005
"Biotechnology and pharmaceutical companies are often driven by profit goals, but the case studies in Bioindustry Ethics show that this is increasingly not at the expense of ethical integrity. ...lend[s] important insights to other executives and professionals who might be developing their own practices and policies."
- GENOMICS & PROTEOMICS (August 2005)
This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics.
Ethics in an Emerging Field